Targeted wound care Identify opportunities with healthcare providers and facilities focused on wound healing and hemostasis, leveraging Marine Polymer Technologies' biomaterials portfolio to enhance acute care, surgical, and trauma workflows.

SMB growth potential With a lean team and revenue in the low-to-mid multi-million range, pursue partnerships with mid-size medical device distributors and regional suppliers to scale adoption of MPT’s innovative biomaterials across hospitals and outpatient centers.

Tech-enabled engagement Utilize the company’s digital footprint and analytics stack to target procurement and clinical decision-makers using data-driven outreach, audits of adoption barriers, and pilot program offers to validate value propositions.

Strategic collaborations Position MPT as a complement to large players in wound care and hemostasis by proposing joint development, co-branding, or integration opportunities that align with the capabilities of bigger pharma and medtech firms.

Competitive landscape fit Highlight differentiators such as innovative biomaterials and decades-long focus on bleeding control to engage customers near competitors like Stryker, Allergan, and Integra, while targeting high-need segments and regional hospitals seeking alternatives to incumbents.